FDA Investigator Charles M Kerns, BLT DO
Charles M Kerns, BLT DO has conducted inspections on 73 sites in 1 countries as of 09 May 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
73
Last Inspection Date:
09 May 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Charles M Kerns, BLT DO:
Amber G Chung,
Ana P Barido,
Andrew J Howard,
Andrew R Wasko,
Ashley M Whitehurst,
Barbara A Burke,
Barbara A Gullick,
Barbara J Holladay,
Brandon L Mariner,
Brian M Palermo,
Carla C Tuite,
Carol Rivera Lopez, PhD,
Catherine Whiteside, PhD,
Charlean R Butler,
Charles A Snipes, PhD,
Charles D Boison,
Christine M O'leary,
Christine M Whitby, CSO,
Christopher B May,
Christopher R Richardson,
Claudette D Brooks,
Collins M Mason,
Conrad M Guardia,
Courtney N Long,
Ct Viswanathan, PhD,
Cynthia A Harris, MD, RN,
Daniel R Azar,
Danielle R Rainey,
David K Glasgow,
David L Chon,
David P Rice, Jr,
Denise R Beuttenmuller,
Dirk L Lincoln,
Dr. Abhijit Raha, PhD,
Edward P Potter,
Ellen A Humphrey,
Elvis D Morton,
Emest F Bizjak,
Erin L Mcfiren,
Esaw,
Gail L Katz,
Gajendiran Mahadevan, PhD,
Gale L Glinecki,
Gerald N Mcgirl, DDS,
Gifford Whitehurst, Jr,
Heath R Harley,
Hector Jcolon Torres,
Holly S Simms,
Hugh M Mcclure, II,
Jacqueline A O'shaughnessy, PhD,
James F Mccormack, PhD,
James T Mccoy,
James W Leonette,
Jamie D Richardson,
Jamie D Swann,
Janete F Guardia,
John Dan,
John J Welsh, PhD,
John Kadavil, PhD,
John M Gusto,
Johnson,
Jonathan W Chapman,
Joseph A Morkunas,
Joseph S Fanelli,
Joseph W Matthews,
Jude C Dikes,
Julie A Silberberg,
Karen A Spencer,
Kenneth L Smalls,
Kenneth Nieves,
Krista N Flores,
La Tasham Gunter,
Lakisha M Williams,
Laurissa S Flowers,
LCDR Anastasia M Piliafas Brown,
LCDR Wilfred A Darang,
Linda S Mattingly,
Lori S Lawless,
LT Melanie M Mayor, USPHS,
Lynette P Salisbury,
Margaret H Waters,
Marion W Nadeau,
Mary K Leslie,
Marya F Ricks,
Melissa J Garcia,
Michael F Skelly, PhD,
Mildred L Mccray,
Miriam D Stuckey,
Mohamad A Chahine,
Nancy L Meade,
Nina D Patel,
Nisha C Patel,
Patricia A Morrow,
Pelekakis,
Regina Gibson Melton,
Renisha M Shaw,
Rina Bhikha,
Ronald T Nowalk,
Sam H Haidar, PhD,
Shelby W Brown, Jr,
Sherry L Secrist, BLT DO,
Shusheen A Alexander,
Sierra M Shockley,
Slatten,
Stacey A Priest,
Stephanie L Shapley,
Stephen C Eason,
Steven J Thurber,
Susan J Essenmacher,
Sylvia R Dooling,
Tajah L Blackburn,
Tamara N Champion,
Tamika E Allen, RN,
Tania E Vizcaino,
Thomas J Hudson,
Tracy L Taras, PhD,
Tressa T Lewis,
Victoria V Bot,
Walter L Fava,
Wanda Y Honeyblue,
Wayne L Jefferson,
William D Murray,
William H Linkroum,
Xiaohan Cai, PhD
Charles M Kerns, BLT DO's Documents
Publish Date | Document Type | Title |
---|---|---|
October, 2003 | EIR | Ore Pharmaceuticals Inc - EIR, 2003-10-17 |
June, 2004 | EIR | James Ahlgren MD - EIR, 2004-06-30 |
June, 2005 | EIR | Covance Laboratories, Inc. - EIR, 2005-06-24 |
October, 2003 | FDA 483 Response | Ore Pharmaceuticals Inc - Form 483R, 2003-10-27 |
May, 2004 | EIR | John L Marshall MD - EIR, 2004-05-27 |
June, 2005 | FDA 483 | Covance Laboratories, Inc. - Form 483, 2005-06-24 |
October, 2004 | EIR | Michael A Bolognese MD - EIR, 2004-10-26 |
January, 2005 | EIR | Raafat Hannalah MD - EIR, 2005-01-31 |
June, 2002 | EIR | Covance Laboratories, Inc. - EIR, 2002-06-21 |
December, 2004 | FDA 483 | Contec Inc- Sporicidin Division - Form 483, 2004-12-15 |
June, 2002 | FDA 483 Response | Covance Laboratories, Inc. - Form 483R, 2002-06-21 |
June, 2002 | FDA 483 | Covance Laboratories, Inc. - Form 483, 2002-06-21 |
October, 2003 | FDA 483 | Ore Pharmaceuticals Inc - Form 483, 2003-10-17 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more